General Information of the Compound
| Compound ID |
CP0503050
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
ethyl 4-[[(2S)-3-(4-hydroxyphenyl)-1-oxo-1-[[1-[[3-(trifluoromethyl)phenyl]methyl]pyrrolidin-3-yl]amino]propan-2-yl]carbamoylamino]benzoate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H33F3N4O5
|
||||||||||||||||||
| Molecular Weight |
598.622
|
||||||||||||||||||
| Canonical SMILES |
CCOC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)NC2CCN(Cc3cccc(c3)C(F)(F)F)C2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H33F3N4O5/c1-2-43-29(41)22-8-10-24(11-9-22)36-30(42)37-27(17-20-6-12-26(39)13-7-20)28(40)35-25-14-15-38(19-25)18-21-4-3-5-23(16-21)31(32,33)34/h3-13,16,25,27,39H,2,14-15,17-19H2,1H3,(H,35,40)(H2,36,37,42)/t25?,27-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WLYRERZDPMFDFL-GPNIZQGCSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Protein ID: PT01198, Muscarinic acetylcholine receptor M2
Protein ID: PT01266, Muscarinic acetylcholine receptor M3